TEVA 7389 Pill - orange round, 9mm
Pill with imprint TEVA 7389 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Risedronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis; Paget's Disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA 7389
Risedronate Sodium
- Imprint
- TEVA 7389
- Strength
- 35 mg
- Color
- Orange
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-3098
- Inactive Ingredients
-
silicon dioxide,
corn starch,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
sodium stearyl fumarate,
titanium dioxide,
FD&C Yellow No. 6,
ferric oxide yellow,
ferric oxide red,
polysorbate 80
Note: Inactive ingredients may vary.
More about risedronate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (79)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
- Risedronate drug information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
